RAISEing VEGF-D’s importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients
Author:
Funder
European Research Council
National Natural Science Foundation of China
Fritz Thyssen Stiftung
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/29/3/527/24530982/mdy028.pdf
Reference26 articles.
1. Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study;Tabernero;Ann Oncol,2018
2. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
3. Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial;Cohn;Cancer Chemother Pharmacol,2017
4. Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy;Verdaguer;Ther Adv Med Oncol,2016
5. Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab;Arnold;Ann Oncol,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Variations of VEGFR2 Chemical Space: Stimulator and Inhibitory Peptides;International Journal of Molecular Sciences;2024-07-16
2. Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors;International Journal of Molecular Sciences;2023-08-28
3. KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?;International Journal of Molecular Sciences;2021-12-17
4. Einfluss der Molekularpathologie auf die onkologische Chirurgie des kolorektalen Karzinoms;Der Chirurg;2021-08-27
5. Therapeutische Relevanz molekularer Marker beim kolorektalen Karzinom;Der Onkologe;2020-05-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3